BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/11/2025 2:19:31 AM | Browse: 83 | Download: 368
 |
Received |
|
2024-11-04 11:29 |
|
Peer-Review Started |
|
2024-11-04 11:29 |
|
First Decision by Editorial Office Director |
|
2025-02-26 02:25 |
|
Return for Revision |
|
2025-02-26 02:25 |
|
Revised |
|
2025-02-28 08:55 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-03-10 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-03-10 05:20 |
|
Articles in Press |
|
2025-03-10 05:20 |
|
Edit the Manuscript by Language Editor |
|
2025-03-11 11:03 |
|
Typeset the Manuscript |
|
2025-03-25 00:23 |
|
Publish the Manuscript Online |
|
2025-04-11 02:19 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Chinese patent medicine: Opening new perspectives for the treatment of post-endoscopic submucosal dissection esophageal stricture in esophageal cancer patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jie-Yu Guo, Xue-Ying Dong, Shi Li, Jing-Feng Tang and Ce-Fan Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82370715 |
| National Natural Science Foundation of China |
No. 32270768 |
| National Natural Science Foundation of China |
No. 82273970 |
| National Key R and D Program of China |
No. 2023YFC2507904 |
| Innovation Group Project of Hubei Province |
No. 2023AFA026 |
|
| Corresponding Author |
Ce-Fan Zhou, PhD, Professor, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, School of Life and Health Sciences, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, No. 28 Nanli Road, Wuhan 430068, Hubei Province, China. cefan@hbut.edu.cn |
| Key Words |
Post-endoscopic submucosal dissection; Esophageal stricture; Kangfuxin; Transforming growth factor-β1; Smad2/3 |
| Core Tip |
Post-endoscopic submucosal dissection esophageal stricture significantly affects patients' quality of life; however, current treatment options are inadequate to meet clinical demands. In this letter, we first examine the limitations of existing treatment methods for esophageal stricture. We then introduce the novel therapeutic agent Kangfuxin solution and elucidate its mechanisms of action. Finally, we explore some emerging treatment technologies and propose potential avenues for future research. |
| Publish Date |
2025-04-11 02:19 |
| Citation |
Guo JY, Dong XY, Li S, Tang JF, Zhou CF. Chinese patent medicine: Opening new perspectives for the treatment of post-endoscopic submucosal dissection esophageal stricture in esophageal cancer patients. World J Gastroenterol 2025; 31(14): 102943 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i14/102943.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i14.102943 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
